Mohammad Hossein Modarressi
Overview
Explore the profile of Mohammad Hossein Modarressi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
1337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shariati A, Khezrpour A, Shariati F, Afkhami H, Yarahmadi A, Alavimanesh S, et al.
Front Immunol
. 2025 Jan;
15:1498431.
PMID: 39872522
Cancer is one of the leading causes of mortality around the world and most of our conventional treatments are not efficient enough to combat this deadly disease. Harnessing the power...
2.
Alavimanesh S, Nayerain Jazi N, Choubani M, Saeidi F, Afkhami H, Yarahmadi A, et al.
Clin Exp Med
. 2025 Jan;
25(1):44.
PMID: 39849183
Cellular senescence is understood to be a biological process that is defined as irreversible growth arrest and was originally recognized as a tumor-suppressive mechanism that prevents further propagation of damaged...
3.
Jamali Z, Zargar M, Modarressi M
Mol Biol Res Commun
. 2025 Jan;
14(1):47-58.
PMID: 39744514
Testis specific gene antigen 10 (TSGA10) is a protein which has roles in spermatogenesis and cancers so that deletion or mutation in the gene resulted in non-obstructive infertility and aberrant...
4.
Shariati A, Khani P, Nasri F, Afkhami H, Khezrpour A, Kamrani S, et al.
Biomark Res
. 2024 Dec;
12(1):157.
PMID: 39696625
Harnessing the power of the immune system to target cancer cells is one of the most appealing approaches for cancer therapy. Among these immunotherapies, messenger ribonucleic acid (mRNA) cancer vaccines...
5.
Etemadzadeh A, Salehipour P, Motlagh F, Khalifeh M, Asadbeigi A, Tabrizi M, et al.
J Clin Lab Anal
. 2024 Oct;
38(21):e25101.
PMID: 39445676
Background: Accurate detection of the BRAF V600E (1799T > A) mutation status can significantly contribute to selecting an optimal therapeutic strategy for diverse cancer types. CRISPR-based diagnostic platforms exhibit simple...
6.
Asadbeigi A, Bakhtiarizadeh M, Saffari M, Modarressi M, Sadri N, Ziafati Kafi Z, et al.
Mol Ther Nucleic Acids
. 2024 Jul;
35(3):102235.
PMID: 39021763
The intrinsic nature of CRISPR-Cas in conferring immunity to bacteria and archaea has been repurposed to combat pathogenic agents in mammalian and plant cells. In this regard, CRISPR-Cas13 systems have...
7.
Farshadzadeh Z, Pourhajibagher M, Taheri B, Ekrami A, Modarressi M, Azimzadeh M, et al.
BMC Microbiol
. 2024 Jan;
24(1):12.
PMID: 38172665
No abstract available.
8.
Motlagh F, Soleimanpour-Lichaei H, Shamsara M, Etemadzadeh A, Modarressi M
Adv Pharm Bull
. 2023 Nov;
13(4):799-805.
PMID: 38022811
Purpose: Fetal hemoglobin (HbF) upregulation is a mitigating factor in β-hemoglobinopathies therapy like β-thalassemia and sickle cell diseases. Finding molecular mechanisms and the key regulators responsible for globin switching could...
9.
Rasti A, Abazari O, Dayati P, Kardan Z, Salari A, Khalili M, et al.
Adv Biomed Res
. 2023 Aug;
12:157.
PMID: 37564439
Background: Growing evidence strongly indicates pivotal roles of gender differences in the occurrence and survival rate of patients with bladder cancer, with a higher incidence in males and poorer prognosis...
10.
Mahmoodi M, Karami F, Abdollahi H, Giahi N, Divsalar K, Honarmand A, et al.
Addict Health
. 2023 Aug;
15(2):87-92.
PMID: 37560396
Background: Opiate abuse has been critically increased in the world, especially in Iran. Owing to the association of opiate use with multiple human cancers and neurological disorders, seeking for genetic...